The long-chain base phytosphingosine is a component of sphingolipids and exists in yeast, plants, and some mammalian tissues. Phytosphingosine is unique in that it possesses an additional hydroxyl group compared to other long-chain bases. However, its metabolism is unknown. Here we show that phytosphingosine is metabolized to odd-numbered fatty acids and is incorporated into glycerophospholipids both in yeast and mammalian cells. Disruption of the yeast gene encoding long-chain base 1-phosphate lyase, which catalyzes the committed step in the metabolism of phytosphingosine to glycerophospholipids, causes a ~40% reduction in the level of phosphatidylcholines that contain a C15 fatty acid. We also find that 2-hydroxypalmitic acid is an intermediate of the phytosphingosine metabolic pathway.
INTRODUCTION
Cell membranes contain thousands of lipid species, which have compositions specific to each organism, tissue, cell, and organelle and become altered in response to environmental changes.
Cell membranes with certain lipid compositions exhibit characteristic properties of fluidity, thickness, curvature, and local crowding (lipid microdomain), affecting protein activities and cellular signaling. Maintenance of cell-or tissue-specific lipid composition is important for cellular activity, and its deregulation leads to disorders. Fatty acids (FAs), the hydrophobic backbones of most lipid classes, are diverse molecules differing in chain-length, degree of saturation, and modification state, for instance, hydroxylation. Most cellular FAs contain even-numbered chain-lengths. However, odd-numbered FAs also exist, albeit at much lesser levels compared to even-numbered FAs [1] [2] [3] [4] . Sphingolipids are one of the major lipid classes in eukaryotes. Their roles are not restricted to building blocks of plasma membrane but also include cell adhesion, recognition of viruses and bacterial toxins, skin barrier formation, neural functions, apoptosis, and glucose metabolism [5] [6] [7] [8] [9] . Furthermore, the sphingolipid metabolite sphingosine 1-phosphate (S1P) functions as a lipid mediator that regulates various cellular responses, such as egress of T cells from the thymus and secondary lymphoid tissues and vascular stabilization, by binding to one of the five S1P receptors (S1P 1-5 ) 6, 10 . Its function in the immune system has already been applied clinically as a therapeutic agent for multiple sclerosis 11 .
The hydrophobic backbone of sphingolipids ceramide is composed of a long-chain base (LCB) and a FA connected by an amide bond 6 . The major LCB in mammals is a trans-double bond-containing sphingosine, which is a precursor of S1P. Sphingosine/LCB is phosphorylated by sphingosine/LCB kinases to produce S1P/LCB 1-phosphate (LCBP). The saturated LCB dihydrosphingosine (DHS) also exists throughout the body, although the levels of DHS are less abundant than those of sphingosine 6 . Phytosphingosine (PHS), which contains a hydroxyl group at the C4 position, is localized to specific tissues such as the skin and small intestine 7, [12] [13] [14] . PHS is a major LCB in yeast, and it also exists in plants 15 .
In addition to the function of S1P/LCBP as a lipid mediator, S1P/LCBP also plays an important role as an intermediate in the sphingolipid-to-glycerophospholipid metabolic pathway 16 . This metabolic pathway is conserved in eukaryotes from yeast to humans, indicating its much older origin than the function of S1P/LCBP as a lipid mediator. We recently identified the complete metabolic pathway of S1P. S1P is metabolized to palmitoyl-CoA via four reactions (cleavage, oxidation, CoA addition, and saturation) and incorporated into glycerophospholipids [17] [18] [19] . DHS is also metabolized to glycerophospholipids after phosphorylation through a pathway that is essentially same as the S1P metabolic pathway, but without the saturation step 17 ( Fig. 1a ). However, current knowledge about the metabolism of PHS is severely lacking. For example, it is even unknown whether PHS is metabolized to glycerophospholipids. If it is metabolized to glycerophospholipids, it still remains unclear whether PHS is incorporated into glycerophospholipids as FA or 2-hydroxy FA.
Several organisms, including bacteria, fungi, plants, and animals, possess 2-hydroxy FAs 20 . In mammals, 2-hydroxy FAs exist in specific tissues such as the epidermis, small intestine, and in myelin 7, 21, 22 . Since deregulated accumulation of biomolecules often leads to cellular dysfunction or disorder, our newly identified PHS metabolic pathway may also be important for the maintenance of proper cellular functions.
Results

PHS is metabolized to odd-numbered FAs
The metabolism of PHS is currently unknown mainly due to the lack of commercially available radioactive PHS. Therefore, we prepared radiolabeled PHS ( [11, H]PHS) from [9, (Fig. 1c) , confirming its identity and purity. We observed additional lipid products in addition to PHS1P following Lcb4 treatment (Fig. 1c, asterisk) . Similar lipids were reported in a previous study 25 , where the authors concluded that these lipids were generated during the TLC separation. (Fig. 1d ). Consistent with a previous report 17 ( Fig. 1a) , DHS was metabolized to sphingolipids (ceramide, inositol phosphorylceramide (IPC)), mannosylinositol phosphorylceramide (MIPC), and mannosyldiinositol phosphorylceramide (M(IP) 2 C)) and glycerophospholipids (PC, phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylinositol (PI)).
Similar to DHS metabolism, PHS was metabolized to both sphingolipids and glycerophospholipids, but with the metabolic flow to sphingolipids being predominant (Fig.   1e ).
To characterize the FA composition of these glycerophospholipids, [ (Fig. 2a,b ).
The contribution of PHS-to-glycerophospholipid metabolism to cellular odd-numbered (Fig. 2c) . Deletion of the DPL1 gene caused a reduction in total C15 PC levels to ~40% of wild-type levels (Fig. 2d) . Some PC species with an elongated C17 FA were also decreased ( Fig. 2c ), while those with two even-numbered FAs were mostly unaffected (Fig. 2e) . Similar results were obtained when the deletion mutant of the SUR2 gene, which encodes the DHS C4-hydroxylase producing PHS from DHS, was analyzed ( Supplementary Fig. 2 ).
When the pAN9 plasmid, which encoded the 3xFLAG-tagged DPL1 gene under the control of the GAPDH promoter, was introduced into the Δdpl1 cells, C15 and C17 PC levels increased greatly, even when compared to the wild-type control ( Supplementary Fig. 3 ).
Furthermore, addition of PHS to the culture medium caused a large increase in odd-numbered PCs ( Supplementary Fig. 4 ). Levels of some even-numbered PCs were also slightly altered by exogenous PHS. In summary, PHS is metabolized to odd-numbered FAs, and PHS appears to 8 be a major source of odd-numbered FAs in yeast.
LCBP lyase is a key determinant of LCB/LCBP metabolism
The metabolism of PHS to glycerophospholipids was less efficient than that of DHS (Fig. 1d) 3a) . Incubation of wild-type membranes with DHS1P produced almost equal amounts of phosphoethanolamine and phosphate (a 0.92:1 ratio), whereas phosphate was preferentially generated from PHS1P (a 0.45:1 ratio) (lines 3 and 4; see Fig. 3b for quantified data). Deletion of the sole LCBP lyase DPL1, (Δdpl1 cell membranes) did not produce phosphoethanolamine (lanes 5 and 6) ; however, deletion of the LCBP phosphatase Lcb3, the more predominant one of the two (Ysr3 being the other) 26 , was not sufficient to prevent the production of phosphate but reduced it with a concomitant increase of phosphoethanolamine (lanes 7 and 8) . The lipid phosphate phosphatases Lpp1 and Dpp1 in yeast are known to exhibit broad specificity toward lipid phosphates 27 . Accordingly, DHS1P/PHS1P dephosphorylation was eliminated by using membranes of the Δlcb3 Δysr3 Δlpp1 Δdpp1 quadruple deletion mutant (lanes 9 and 10 ). This 9 result is consistent with our previous data indicating that membranes of the Δlcb3 Δlpp1
Δdpp1 triple deletion mutant had no phosphatase activity toward DHS1P 28 . Even under these phosphatase-null conditions, conversion of PHS1P to phosphoethanolamine was low (lane 10).
The above results suggest that the differences in the metabolism of DHS and PHS ( Immunoblotting revealed that expression levels of 3xFLAG-Dpl1 and 3xFLAG-Lcb3 were equivalent ( Fig. 3c) . We determined the V max and K m values for Dpl1 to be 28.3 nmol/μg/min and 19.6 μM for DHS1P and 8.9 nmol/μg/min and 10.6 μM for PHS1P, respectively (Fig. 3d) .
Thus, the V max value of Dpl1 toward PHS1P is ~1/3 of that toward DHS1P, indicating that the activity of Dpl1 toward PHS1P was indeed low. On the other hand, the kinetic parameters of 
2-hydroxypalmitic acid is an intermediate in PHS metabolism
We previously reported that DHS was metabolized to glycerophospholipids via DHS1P, hexadecanal, palmitic acid, and palmitoyl-CoA 17 ( Fig. 1a) . The LCB kinase Lcb4, LCBP lyase Dpl1, fatty aldehyde dehydrogenase Hfd1, and acyl-CoA synthetases Faa1 and Faa4 are involved in each conversion step 17 ( Fig. 1a) . We next examined whether these enzymes were also involved in PHS metabolism. The PHS-to-glycerophospholipid conversion was completely abolished in Δlcb4, Δdpl1, Δhfd1, and Δfaa1 Δfaa4 cells ( 
MPO1 is involved in the metabolism of PHS
The results described above indicate that PHS is metabolized to 2-hydroxypalmitic acid and then converted to pentadecanoic acid via α-oxidation. To identify a gene involved in α-oxidation of PHS metabolites, we performed bioinformatic analysis using a yeast database.
Since LCBP metabolism takes place in the ER 16 , we speculated that the corresponding gene encodes an ER protein. Therefore, we searched for genes encoding ER proteins in the yeast GFP fusion localization database (http://yeastgfp.yeastgenome.org/) 29 Fig. 5 ). Deletion of the MPO1 gene had no effect on DHS metabolism (Fig. 5a ). These results indicate that the MPO1 gene is involved in a PHS-specific reaction, α-oxidation of PHS metabolites. Moreover, (Fig. 5e ). GFP-Mpo1 indeed co-localized with the mCherry-tagged ER marker Sec61.
PHS is metabolized to odd-numbered FAs in mammalian cells
We next examined the metabolism of PHS in mammalian cells using CHO-K1 cells via a We observed production of C15:0 FAME and, to a lesser extent, its elongated product C17:0 FAME, both of which were resistant to KIO 4 /KMnO 4 treatment (Fig. 6b) . By
]DHS-labeling, C16:0 FAME and its elongated product C18:0 FAME were generated ( (Fig. 6e) . Consistent with our previous results
17
, the metabolism of DHS to glycerophospholipids was almost completely abolished in F9 Spl -/-cells. Similarly, the metabolism of PHS to glycerophospholipids was also impaired in F9 Spl -/-cells. Thus, the metabolism of PHS to glycerophospholipids is dependent on S1P lyase in mammalian cells as well as in yeast.
13
Discussion
In the present study, we demonstrate for the first time that PHS is metabolized to glycerophospholipids in both yeast and mammalian cells (Fig. 1d and Fig. 6a,c,e) , as are other
LCBs including sphingosine and DHS
17
. Although sphingosine and DHS were metabolized to palmitic acid (C16:0) and its desaturated (C16:1) or elongated (C18:0) derivative in glycerophospholipids, PHS was converted to odd-numbered pentadecanoic acid (C15:0) and its derivatives (C15:1, C17:0, and 17:1) (Fig. 2 and Fig. 6 ). . FA synthase normally utilizes acetyl-acyl carrier protein (ACP) as a starting material for condensation with malonyl-ACP, producing even-numbered FAs, mainly palmitic acid. However, a small fraction of propionyl-CoA produced during amino acid and cholesterol metabolism appears to be converted to propionyl-ACP, which is then used for FA synthesis. When mice were fed tripropionin, levels of odd-numbered FAs were increased in depot fat 32 . In addition, propionic acidemia patients, who cannot metabolize propionyl-CoA due to a defect in propionyl-CoA decarboxylase, were found to have ~4-5-fold higher levels of odd-numbered FAs in their erythrocytes, plasma, liver, and subcutaneous tissue compared to controls 3 . However, the contribution of the propionate-derived odd-numbered FAs relative to total odd-numbered FAs under normal conditions and other tissues remains unknown. Here, we report that PHS was the major source of odd-numbered FAs, at least in yeast (Fig. 2c,d and Supplementary Fig. 2 ). In mammals, PHS is localized to specific tissues such as the skin and small intestine 7, [12] [13] [14] .
Consistent with the abundance of PHS in skin, odd-numbered FAs also exist in skin at extremely high levels 4 , suggesting that PHS may be the major source of odd-numbered FAs in PHS-rich mammalian tissues.
We observed that the metabolism of PHS to glycerophospholipids depended on the LCB kinase Lcb4, LCBP lyase Dpl1, fatty aldehyde dehydrogenase Hfd1, and acyl-CoA synthetases Faa1 and Faa4 (Fig. 4a) . Therefore, PHS is first converted to PHS1P by Lcb4 and degraded to 2-hydroxyhexadecanal by Dpl1 (Fig. 7) . This degradation step is the key determinant of the metabolic flow of LCB/LCBP (Fig. 3 ). 2-hydroxyhexadecanal is then oxidized to 2-hydroxypalmitic acid by Hfd1 (Fig. 7) . We detected 2-hydroxypalmitic acid and pentadecanoic acid in the medium of Δfaa1 Δfaa4 cells (Fig. 4b) , suggesting that both 2-hydroxypalmitic acid and pentadecanoic acid are substrates of the acyl-CoA synthetases Faa1 and Faa4 in the PHS metabolic pathway. Thus, the Hfd1 product 2-hydroxypalmitic acid may be converted to 2-hydroxypalmitoyl-CoA by Faa1 and Faa4 in the next step (Fig. 7) .
Although the exact role of Mpo1 is unclear at present, Mpo1 must be involved in a PHS-specific reaction, i.e., a reaction that is not involved in DHS metabolism (Fig. 5a ). Given that Mpo1 is a putative NAD + -binding protein, we hypothesize that Mpo1 may be involved in the α-oxidation of 2-hydroxypalmitoyl-CoA, producing pentadecanoic acid or other metabolites such as pentadecanal that can be metabolized to pentadecanoic acid.
Pentadecanoic acid is finally converted to pentadecanoyl-CoA by Faa1 and Faa4 for glycerophospholipid synthesis (Fig. 7) . The observation that pentadecanoic acid was detected in the medium of Δfaa1 Δfaa4 cells (Fig. 4b) suggests that metabolism of at least some 2-hydroxypalmitic acid can still proceed to pentadecanoic acid even in the absence of Faa1 and Faa4. Yeast contain 7 acyl-CoA synthetases (Faa1, Faa2, Faa3, Faa4, Fat1, Fat2, and Acs1).
Therefore, acyl-CoA synthetases other than Faa1 and Faa4 may have residual activity toward 2-hydroxypalmitic acid in Δfaa1 Δfaa4 cells. As 2-hydroxypalmitic acid was detected in the medium of Δmpo1 cells (Fig. 5b) , we speculate that 2-hydroxypalmitoyl-CoA is converted to 2-hydroxypalmitic acid by an acyl-CoA hydrolase and is released into the medium in the Δmpo1 cells.
Although peroxisomes are known to be involved in α-oxidation 34 , we found that Mpo1 was localized to the ER (Fig. 5e ), similar to other enzymes involved in LCBP metabolism 16 .
We examined the involvement of peroxisomes in PHS metabolism by using yeast deletion mutants for the peroxisomal translocation machinery PEX2 and PEX12 and the ABC transporter subunits PXA1 and PXA2 that are required for importing long-chain FA into peroxisomes. However, PHS was metabolized as normal in these mutants ( Supplementary Fig.   7 ). Thus, our results suggest that peroxisomes are unlikely to be involved in PHS metabolism;
instead, all reactions in the PHS metabolic pathway are likely to occur in the ER.
Mpo1 belongs to the large protein family DUF962 (DUF: domain of unknown function), whose functions are unknown at present. Our findings suggest that Mpo1 is involved in the α-oxidation of 2-hydroxyacyl-CoAs. As the function of the DUF962 family has been elucidated here, we will refer to it as the Mpo1 family hereafter. Mpo1 family members exist in bacteria, fungi, plants, and protists; 2-hydroxy FAs also exist in these organisms 20 , although its presence in protists has not been examined. It is therefore highly likely that Mpo1 family members are involved in the α-oxidation of 2-hydroxyacyl-CoAs in general.
Our results indicate that PHS is metabolized to odd-numbered FAs in mammals (Fig. 6 ).
However, Mpo1 family members are not expressed in mammals, in contrast to other LCB/LCBP metabolic enzymes conserved between yeast and mammals 16 . PHS seems to have once disappeared in the course of evolution, when Animalia diverged from Plantae. Therefore, members of lower Animalia do not possess PHS. However, mammals again evolutionarily acquired the ability to produce PHS, likely due to the requirement for PHS to fulfill the functions in specific tissues. We speculate that Mpo1 homologs were lost at the same time as when PHS disappeared in Animalia. Instead, mammals may have independently evolved an α-oxidase from other protein families, when they began to utilize PHS.
LCBs have two hydroxyl groups and one amino group in common, both of which can form hydrogen bonds. Since PHS contains an additional hydroxyl group, PHS may possess different properties compared to other LCBs and specific functions by interacting with other lipids or proteins with higher affinity due to additional hydrogen bond formation. Therefore, PHS may be important for PHS-containing tissues such as the skin and small intestine, and its reduction may lead to disorders. Indeed, a decrease in PHS-containing ceramide levels has been observed in psoriatic scale 35 . In addition, the degradation pathway must also be important for the maintenance of appropriate levels of PHS, as it is for other biomolecules in general.
Indeed, several metabolic disorders, including sphingolipidoses 36 , are known to be due to defects in certain lipid degradation pathway. The PHS metabolite, odd-numbered FAs, is much less common than even-numbered FAs, and both are similarly metabolized to glycerophospholipids. Thus, odd-numbered FA itself might not have physiological significance.
However, the PHS metabolic pathway that we have elucidated here may be important for the maintenance of cellular PHS levels and clearance of PHS metabolites such as 2-hydroxy FAs, and disorders can arise from its deregulation. Both PHS and 2-hydroxypalmitic acid are incorporated into sphingolipids only, and are not used in other lipids. In addition, they cannot to be subjected to β-oxidation in their current forms. The PHS metabolic pathway revealed here converts them to the metabolizable compound, non-hydroxylated pentadecanoic acid.
Pentadecanoic acid can undergo desaturation, elongation, incorporation into glycerophospholipids, and mitochondrial β-oxidation, where the final round product propionyl-CoA is converted to succinyl-CoA and subsequently metabolized in the citric acid cycle 37 .
In mammals, there remain a large number of orphan G protein-coupled receptors (GPCRs). Recent developments in lipidomics analysis have led to the discovery of many novel lipid metabolites, some of which have been determined to be ligands of orphan GPCRs. Our elucidation of the PHS metabolic pathway encourages the search for novel bioactive lipid molecules in the derivatives of PHS metabolites.
Methods
Yeast strains and media
The Saccharomyces cerevisiae strains used in this study are listed in Supplementary Table 1. BY4741 cells 38 
Plasmids
The pAKNF316 plasmid (URA3 marker) is a yeast expression vector and was designed to produce an N-terminal 3xFLAG-tagged protein under the control of the GAPDH (TDH3)
promoter. The pAN9 (3xFLAG-DPL1) and pAN13 (3xFLAG-LCB3) plasmids were to the top. PHS was scraped from the TLC plate and was extracted three times using 200 μl ethanol. Silica gel was removed by centrifugation, and the collected lipids were combined. The obtained PHS was estimated to be 0.025 μCi/μl by measuring its radioactivity using a liquid scintillation counter (LSC-3600; Aloka, Tokyo, Japan) and to be 0.55 mM by comparing its ninhydrin-stained density with cold PHS standard (Enzo Life Sciences, Farmingdale, NY).
To phosphorylate [11, 12- mM ATP, and 10 mM MgCl 2 ) containing 0.5 mg/ml FA-free BSA (A6003; Sigma). Soluble, non-palmitoylated 3xFLAG-Lcb4 was purified as described previously 42 , by subjecting the soluble fraction prepared from the palmitoyltransferase mutant KHY543 (Δakr1) cells harboring the pTS229 (3xFLAG-LCB4) plasmid to incubation with anti-FLAG M2 agarose (Sigma), followed by extensive washing and elution with buffer containing 100 μg/ml 3xFLAG peptide. Lipids were extracted by successive addition and mixing of 187. Table 2 , was selected at Q1 ( Supplementary Fig. 8 ), and their FA compositions were determined by analyzing their fragment ions (Supplementary Table 3 and Supplementary   Fig. 9 ). Argon gas was used as the collision gas, and collision energy was set at 30 V. Data analysis and quantification were performed using MassLynx software (Waters). For quantification, levels of PC species with the same molecular mass were first determined by comparing their ion intensities with those of the internal standards in the first MS analyses, and levels of each PC species having specific FA composition were then calculated by comparing the ion intensities of their fragments in the MS/MS analysis.
Immunoblotting
Immunoblotting was performed as described previously [11,12- data are expressed as the mean ± S.D. relative to the radioactivity in the total lipids from three independent experiments. Statistically significant differences are indicated (Student's t-test; *, p < 0.05; **, p < 0.01). 
